Commonwealth Equity Services
NMTR

Commonwealth Equity Services’s 9 Meters Biopharma NMTR Stock Holding History

Commonwealth Equity Services’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37,905
Closed -$25K – 3986
2023
Q2 		$25K Buy
37,905
+20
+0.1% +$18 ﹤0.01% 3735
2023
Q1 		$52 Sell
37,885
-256
-0.7% -$483 ﹤0.01% 3580
2022
Q4 		$48K Buy
38,141
+18,411
+93% +$42K ﹤0.01% 3521
2022
Q3 		$84K Buy
19,730
+5,210
+36% +$25.8K ﹤0.01% 3403
2022
Q2 		$75K Buy
14,520
+4,000
+38% +$37.7K ﹤0.01% 3422
2022
Q1 		$126K Buy
10,520
+1,915
+22% +$26.1K ﹤0.01% 3440
2021
Q4 		$168K Buy
8,605
+952
+12% +$21.3K ﹤0.01% 3350
2021
Q3 		$198K Buy
7,653
+3,853
+101% +$90.8K ﹤0.01% 3281
2021
Q2 		$83K Buy
3,800
+170
+5% +$4.17K ﹤0.01% 3426
2021
Q1 		$84K Buy
3,630
+2,875
+381% +$88.3K ﹤0.01% 3295
2020
Q4 		$12K Buy
+755
New +$12.6K ﹤0.01% 3186

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Commonwealth Equity Services's NMTR Position: Q3 2023 in Review

Commonwealth Equity Services sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 37,905 shares — an estimated $25K sold.

Commonwealth Equity Services first reported a position in NMTR in Q4 2020 and held it in 11 quarters. The position peaked at $198K in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Commonwealth Equity Services reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 37,905 9 Meters Biopharma shares in Q3 2023, an estimated $25K.
  • Commonwealth Equity Services first reported a position in 9 Meters Biopharma in Q4 2020 and held it in 11 quarters.
  • Commonwealth Equity Services's 9 Meters Biopharma position peaked at $198K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.